Proteomic Studies for the Characterization of the Biological Targets of Marine Bioactive Molecules
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 March 2021) | Viewed by 4613
Special Issue Editor
2. Marine Ecology Research Centre, Southern Cross University, Lismore, Military Rd., East Lismore, NSW 2480, Australia
Interests: marine biology; sequencing; molecular biology; biomedical products; gene expression; genomics; molecular genetics; epigenetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The marine environment makes up to 71% of the Earth surface and is a rich source of bioactive compounds and natural medicines. Marine bioactive molecules are important in relation to drug discovery, specifically if characterized with antitumor, anti-inflammatory, antiviral, and other pharmacological activities. The potential for marine natural bio-products to be used as new drugs is still in relatively new stages of the development. The focus of this special issue is to provide updates about recent proteomics studies using marine organisms as a source of bioactive molecules and new technologies applied. The huge potential of modern next-generation high-throughput sequencing technologies in the combination with liquid chromatography–mass spectrometry, are currently advancing our understanding of protein function and genetics. This is important for the development of novel drugs, which is expending the possibilities for the discoveries and characterizations of new biomolecules for treatment of various diseases.
I invite researchers from different disciplines including chemistry, medical science, nanotechnology, biotechnology, biochemistiries and other fields to consider making contribition to this Special Issue. I encourage my collueges to submit original research articles and review papers to update the curent body of knowledge and to promote the application of proteomics studies in providing better understanding of proteins functional role in health and diseases.
Dr. Nedeljka Rosic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Proteomics
- Bioproducs
- Marine drugs
- Marine toxins
- Liquid chromatography
- Sequencing
